» Articles » PMID: 38390652

Measuring Waning Protection from Seasonal Influenza Vaccination During Nine Influenza Seasons, Ontario, Canada, 2010/11 to 2018/19

Abstract

BackgroundWaning immunity from seasonal influenza vaccination can cause suboptimal protection during peak influenza activity. However, vaccine effectiveness studies assessing waning immunity using vaccinated and unvaccinated individuals are subject to biases.AimWe examined the association between time since vaccination and laboratory-confirmed influenza to assess the change in influenza vaccine protection over time.MethodsUsing linked laboratory and health administrative databases in Ontario, Canada, we identified community-dwelling individuals aged ≥ 6 months who received an influenza vaccine before being tested for influenza by RT-PCR during the 2010/11 to 2018/19 influenza seasons. We estimated the adjusted odds ratio (aOR) for laboratory-confirmed influenza by time since vaccination (categorised into intervals) and for every 28 days.ResultsThere were 53,065 individuals who were vaccinated before testing for influenza, with 10,264 (19%) influenza-positive cases. The odds of influenza increased from 1.05 (95% CI: 0.91-1.22) at 42-69 days after vaccination and peaked at 1.27 (95% CI: 1.04-1.55) at 126-153 days when compared with the reference interval (14-41 days). This corresponded to 1.09-times increased odds of influenza every 28 days (aOR = 1.09; 95% CI: 1.04-1.15). Individuals aged 18-64 years showed the greatest decline in protection against influenza A(H1N1) (aOR = 1.26; 95% CI: 0.97-1.64), whereas for individuals aged ≥ 65 years, it was against influenza A(H3N2) (aOR = 1.20; 95% CI: 1.08-1.33). We did not observe evidence of waning vaccine protection for individuals aged < 18 years.ConclusionsInfluenza vaccine protection wanes during an influenza season. Understanding the optimal timing of vaccination could ensure robust protection during seasonal influenza activity.

Citing Articles

Population-Based Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza Infection in Southern China, 2023-2024 Season.

Gao X, Sun Y, Shen P, Guo J, Chen Y, Yin Y Open Forum Infect Dis. 2024; 11(9):ofae456.

PMID: 39220659 PMC: 11365065. DOI: 10.1093/ofid/ofae456.


Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season.

Grohskopf L, Ferdinands J, Blanton L, Broder K, Loehr J MMWR Recomm Rep. 2024; 73(5):1-25.

PMID: 39197095 PMC: 11501009. DOI: 10.15585/mmwr.rr7305a1.

References
1.
Black S, Nicolay U, Vesikari T, Knuf M, Del Giudice G, Della Cioppa G . Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children. Pediatr Infect Dis J. 2011; 30(12):1081-5. DOI: 10.1097/INF.0b013e3182367662. View

2.
Seidman J, Richard S, Viboud C, Miller M . Quantitative review of antibody response to inactivated seasonal influenza vaccines. Influenza Other Respir Viruses. 2011; 6(1):52-62. PMC: 3175249. DOI: 10.1111/j.1750-2659.2011.00268.x. View

3.
Belongia E, Sundaram M, McClure D, Meece J, Ferdinands J, VanWormer J . Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season. Vaccine. 2014; 33(1):246-51. PMC: 7463277. DOI: 10.1016/j.vaccine.2014.06.052. View

4.
Petrie J, Ohmit S, Johnson E, Truscon R, Monto A . Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination. J Infect Dis. 2015; 212(12):1914-22. PMC: 4655854. DOI: 10.1093/infdis/jiv313. View

5.
Young B, Mak T, Ang L, Sadarangani S, Ho H, Wilder-Smith A . Influenza vaccine failure in the tropics: a retrospective cohort study of waning effectiveness. Epidemiol Infect. 2020; 148:e299. PMC: 7801929. DOI: 10.1017/S0950268820002952. View